-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Biomarin Pharmaceutical Inc annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2020.
- Biomarin Pharmaceutical Inc Operating Lease, Payments for the quarter ending March 31, 2020 was $1.44 M, a 10% decline year-over-year.
- Biomarin Pharmaceutical Inc annual Operating Lease, Payments for 2023 was $9.98 M, a 7.25% decline from 2022.
- Biomarin Pharmaceutical Inc annual Operating Lease, Payments for 2022 was $10.8 M, a 0.9% increase from 2021.
- Biomarin Pharmaceutical Inc annual Operating Lease, Payments for 2021 was $10.7 M, a 1.22% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)